Suchergebnisse - "Dupilumab"

PubPharm (146)

1

Anti-immunoglobulin E provides an additional therapy to conventional steroids for Kimura's disease

enthalten in: The Journal of dermatology | 2024

von Ao, S. | Huang, G. | Tang, X. | +4

2

Biological treatments in childhood asthma

enthalten in: Current opinion in allergy and clinical immunology | 2024

von Nieto-García, A. | Nieto-Cid, M. | Mazón-Ramos, �.

3

Management of vernal keratoconjunctivitis : Navigating a changing treatment landscape

enthalten in: Survey of ophthalmology | 2024

von Ali, A. | Bielory, L. | Dotchin, S. | +3

4

The Role of Biologics in the Treatment of Food Allergy

enthalten in: The journal of allergy and clinical immunology. In practice | 2024

von Sindher, S. | Fiocchi, A. | Zuberbier, T. | +3

5

Multidisciplinary Decision-Making-ITAlian Consensus After Two Years of Real Practice on the Management of Severe Uncontrolled CRSwNP by Biologics (ITACA Study)

enthalten in: Current allergy and asthma reports | 2024

von De Corso, E. | Pipolo, C. | Caminati, M. | +23

6

Multidisciplinary Decision-Making—ITAlian Consensus After Two Years of Real Practice on the Management of Severe Uncontrolled CRSwNP by Biologics (ITACA Study)

enthalten in: Current allergy and asthma reports | 2024

von De Corso, E. | Pipolo, C. | Caminati, M. | +23

7

Comparative Impact of Asthma Biologics : A Nationwide US Claim-Based Analysis

enthalten in: The journal of allergy and clinical immunology. In practice | 2024

von Al-Shaikhly, T. | Norris, M. | Dennis, E. | +2

8

Switching of biological therapy to dupilumab in comorbid patients with severe asthma and CRSwNP

enthalten in: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery | 2024

von Rosso, C. | De Corso, E. | Conti, V. | +11

9

Comparison of clinical remission criteria for severe asthma patients receiving biologic therapy

enthalten in: Respiratory medicine | 2024

von Breslavsky, A. | Al Qaied, A. | Tsenter, P. | +4

10

Cost-effectiveness analysis of dupilumab versus omalizumab, mepolizumab, and benralizumab added to the standard of care in adults with severe asthma in Colombia

enthalten in: Expert review of pharmacoeconomics & outcomes research | 2024

von Ali, A. | García, E. | Torres-Duque, C. | +6

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[15]